Biocryst Pharmaceuticals Inc. (BCRX) Has Risen 0.60%, Becoming A Winning Stock For Investors
Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) has a beta value of 1.96 and has seen 0.54 million shares traded in the recent trading session. The company, currently